Atlas Trials

A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia

Clinical trial NCT05662319 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05662319
Sponsor
Sanofi
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Hemophilia
Start date
2023-02-01
Primary completion
2027-03-25
Enrollment
91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.